Perrigo reported $362.9M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
AbbVie USD 9.34B 1.36B Mar/2025
Abbott USD 5.87B 50M Jun/2025
Bayer EUR 6.38B 1.74B Jun/2025
Bristol-Myers Squibb USD 8.9B 714M Jun/2025
Corcept Therapeutics USD 191M 36.19M Jun/2025
Dr.Reddys Laboratories INR 48.63B 8.16B Jun/2025
Eli Lilly USD 13.11B 2.61B Jun/2025
J&J USD 14.6B 816M Mar/2025
Merck USD 12.99B 224M Jun/2025
Nestle CHF 10.4B 11.03B Jun/2025
Pacira USD 125.91M 8.71M Jun/2025
Perrigo USD 362.9M 29.4M Jun/2025
Pfizer USD 10.88B 248M Jun/2025
Prestige Brands USD 140.33M 29.68M Jun/2025
Reckitt Benckiser GBP 4.25B 2.08B Dec/2024
Sanofi EUR 7.74B 26M Jun/2025
Supernus Pharmaceuticals USD 127.81M 6.25M Jun/2025
Teva Pharmaceutical Industries USD 2.1B 188M Jun/2025
Xeris Pharmaceuticals USD 59.64M 9.02M Jun/2025
Zoetis USD 1.78B 180M Jun/2025